BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 34484467)

  • 21. miR-504 suppresses mesenchymal phenotype of glioblastoma by directly targeting the FZD7-mediated Wnt-β-catenin pathway.
    Liu Q; Guan Y; Li Z; Wang Y; Liu Y; Cui R; Wang Y
    J Exp Clin Cancer Res; 2019 Aug; 38(1):358. PubMed ID: 31419987
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MCPIP1 inhibits Wnt/β-catenin signaling pathway activity and modulates epithelial-mesenchymal transition during clear cell renal cell carcinoma progression by targeting miRNAs.
    Gorka J; Marona P; Kwapisz O; Waligórska A; Pospiech E; Dobrucki JW; Rys J; Jura J; Miekus K
    Oncogene; 2021 Dec; 40(50):6720-6735. PubMed ID: 34657130
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long intergenic non-coding RNA 1939 eliminates proliferation and migration of human renal cell carcinoma (RCC) cells by down-regulation of miR-154.
    Zhang R; Zhang W; Xu B; Lv C; Hou J; Zhang G
    Artif Cells Nanomed Biotechnol; 2020 Dec; 48(1):695-702. PubMed ID: 32138544
    [TBL] [Abstract][Full Text] [Related]  

  • 24. LINC00665 activates Wnt/β-catenin signaling pathway to facilitate tumor progression of colorectal cancer via upregulating CTNNB1.
    Han T; Gao M; Wang X; Li W; Zhuo J; Qu Z; Chen Y
    Exp Mol Pathol; 2021 Jun; 120():104639. PubMed ID: 33865827
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Knockdown of ALPK2 blocks development and progression of renal cell carcinoma.
    Jiang J; Han P; Qian J; Zhang S; Wang S; Cao Q; Shao P
    Exp Cell Res; 2020 Jul; 392(2):112029. PubMed ID: 32330508
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MicroRNA-200b is downregulated and suppresses metastasis by targeting LAMA4 in renal cell carcinoma.
    Li Y; Guan B; Liu J; Zhang Z; He S; Zhan Y; Su B; Han H; Zhang X; Wang B; Li X; Zhou L; Zhao W
    EBioMedicine; 2019 Jun; 44():439-451. PubMed ID: 31130475
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Brusatol enhances MEF2A expression to inhibit RCC progression through the Wnt signalling pathway in renal cell carcinoma.
    Wang T; Zhou Y; Bao H; Liu B; Wang M; Wang L; Pan T
    J Cell Mol Med; 2023 Dec; 27(23):3897-3910. PubMed ID: 37859585
    [TBL] [Abstract][Full Text] [Related]  

  • 28. microRNA-100 functions as a tumor suppressor in non-small cell lung cancer via regulating epithelial-mesenchymal transition and Wnt/β-catenin by targeting HOXA1.
    Han W; Ren X; Yang Y; Li H; Zhao L; Lin Z
    Thorac Cancer; 2020 Jun; 11(6):1679-1688. PubMed ID: 32364673
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MicroRNA-384 Inhibits the Growth and Invasion of Renal Cell Carcinoma Cells by Targeting Astrocyte Elevated Gene 1.
    Song H; Rao Y; Zhang G; Kong X
    Oncol Res; 2018 Apr; 26(3):457-466. PubMed ID: 28877780
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Circular RNA circ-EGLN3 promotes renal cell carcinoma proliferation and aggressiveness via miR-1299-mediated IRF7 activation.
    Lin L; Cai J
    J Cell Biochem; 2020 Nov; 121(11):4377-4385. PubMed ID: 31904147
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pinin acts as a poor prognostic indicator for renal cell carcinoma by reducing apoptosis and promoting cell migration and invasion.
    Jin M; Li D; Liu W; Wang P; Xiang Z; Liu K
    J Cell Mol Med; 2021 May; 25(9):4340-4348. PubMed ID: 33811436
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impact of an altered Wnt1/β-catenin expression on clinicopathology and prognosis in clear cell renal cell carcinoma.
    Kruck S; Eyrich C; Scharpf M; Sievert KD; Fend F; Stenzl A; Bedke J
    Int J Mol Sci; 2013 May; 14(6):10944-57. PubMed ID: 23708097
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Knockdown of PLOD3 suppresses the malignant progression of renal cell carcinoma via reducing TWIST1 expression.
    Xie D; Li J; Wei S; Qi P; Ji H; Su J; Du N; Zhang X
    Mol Cell Probes; 2020 Oct; 53():101608. PubMed ID: 32585183
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Highly Expressed Antisense Noncoding RNA in the INK4 Locus Promotes Growth and Invasion of Renal Clear Carcinoma Cells via the β-Catenin Pathway.
    Li Q; Tian Y; Hu G; Liang Y; Bai W; Li H
    Oncol Res; 2017 Sep; 25(8):1373-1382. PubMed ID: 28251886
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Targeting NEK2 impairs oncogenesis and radioresistance via inhibiting the Wnt1/β-catenin signaling pathway in cervical cancer.
    Xu T; Zeng Y; Shi L; Yang Q; Chen Y; Wu G; Li G; Xu S
    J Exp Clin Cancer Res; 2020 Sep; 39(1):183. PubMed ID: 32907622
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long non-coding RNA CCAT2 promotes cell proliferation and invasion through regulating Wnt/β-catenin signaling pathway in clear cell renal cell carcinoma.
    Huang JL; Liao Y; Qiu MX; Li J; An Y
    Tumour Biol; 2017 Jul; 39(7):1010428317711314. PubMed ID: 28718366
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhibitor of growth 4 inhibits cell proliferation, migration, and induces apoptosis of renal cell carcinoma cells.
    Sun J; Xie L; Lv J; Zhang W; Lv J; Liang Y; Geng Y; Li X
    J Cell Biochem; 2019 Apr; 120(4):6709-6717. PubMed ID: 30390334
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bromodomain-containing protein 9 promotes hepatocellular carcinoma progression via activating the Wnt/β-catenin signaling pathway.
    Fang D; Wang MR; Guan JL; Han YY; Sheng JQ; Tian DA; Li PY
    Exp Cell Res; 2021 Sep; 406(2):112727. PubMed ID: 34370992
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Phospholipase C delta 1 inhibits WNT/β-catenin and EGFR-FAK-ERK signaling and is disrupted by promoter CpG methylation in renal cell carcinoma.
    Xie J; Zhou J; Xia J; Zeng Y; Huang G; Zeng W; Fan T; Li L; Zeng X; Tao Q
    Clin Epigenetics; 2023 Feb; 15(1):30. PubMed ID: 36849889
    [TBL] [Abstract][Full Text] [Related]  

  • 40. miRNA‑205‑5p functions as a tumor suppressor by negatively regulating VEGFA and PI3K/Akt/mTOR signaling in renal carcinoma cells.
    Huang J; Wang X; Wen G; Ren Y
    Oncol Rep; 2019 Nov; 42(5):1677-1688. PubMed ID: 31545453
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.